Overview
Casana develops the Heart Seat, a smart toilet seat that enables in-home health monitoring by passively collecting health data while the user sits. Data is securely uploaded to the Cloud via WiFi and analyzed by clinical algorithms, with a proprietary bio-identification system ensuring that only the prescribed patient's data is shown to the appropriate healthcare team. This enables continuous monitoring for chronic conditions like hypertension without extra effort from users. Compared to competitors, Casana combines everyday use (sitting on a toilet) with automated data collection and advanced patient identification, reducing the need for frequent doctor visits and enabling remote monitoring and telehealth. The company’s goal is to lower healthcare costs and improve care by integrating health monitoring into the home and providing data management and analysis services to patients, caregivers, and providers.
Work here?Claim your company
Simplify's take
What believers are saying
- July 2026 launch created visible demand; RBJ reported assisted living buyers exceeded expectations.
- Casana priced entry at $199, with $9.99 monthly service after year one.
- Updated FDA wellness guidance in January 2026 opened a clearer commercial path for passive vitals.
What critics are saying
- The Smart Seat is now a wellness product, not a medical device, shrinking reimbursement.
- Limited units and a small initial production run signal supply constraints and weak scale.
- If consumers reject toilet hardware, Casana’s direct-to-home model dies before hospital adoption.
What makes Casana unique
- Casana’s July 21, 2026 Smart Seat turns routine bathroom use into passive monitoring.
- The product tracks multiple vitals without wearables, charging, screens, or behavior changes.
- Rochester manufacturing and decade-long RIT research give Casana proprietary hardware-software integration.
Help us improve and share your feedback! Did you find this helpful?
Funding
Industry standards